Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its 2026 priorities across its five growth pillars focused on advancing product commercialization, regulatory milestones and ...

TNO pioneers microbiome-driven solutions for skin health, creating industry-ready platforms for next-generation personal care ...

Tumor immunotherapy has rapidly emerged as a cornerstone in oncology, revolutionizing the treatment landscape for patients with advanced malignancies.

BUFFALO, N.Y. — Five University at Buffalo researchers are participating in a $17 million multi-institution study funded by the National Institute of Dental and Craniofacial Research (NIDCR), part of ...

Abu Dhabi University (ADU) has announced the inauguration of the Abu Dhabi University Cancer Research Institute (ADU-CRI), a ...

From AI-powered drug discovery to regenerative therapies and next-generation neurology tools, Mayo Clinic researchers made ...

Abu Dhabi University (ADU) has announced the inauguration of the Abu Dhabi University Cancer Research Institute (ADU-CRI), a ...

Nutrition intake fundamentally shapes the composition and function of the gut microbiota, and dysregulation of this microbial ecosystem is a primary driver ...

Abu Dhabi University (ADU) has announced the inauguration of the Abu Dhabi University Cancer Research Institute (ADU-CRI), a ...

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 44th Annual J.P.

WEST LAFAYETTE, Ind., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization (CRO) specializing in nonclinical and ...